Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Goodwill (2021 - 2025)

10x Genomics' Goodwill history spans 5 years, with the latest figure at $4.5 million for Q4 2025.

  • For Q4 2025, Goodwill changed 0.0% year-over-year to $4.5 million; the TTM value through Dec 2025 reached $4.5 million, changed 0.0%, while the annual FY2025 figure was $4.5 million, 0.0% changed from the prior year.
  • Goodwill for Q4 2025 was $4.5 million at 10x Genomics, roughly flat from $4.5 million in the prior quarter.
  • Across five years, Goodwill topped out at $4.5 million in Q4 2021 and bottomed at $4.5 million in Q4 2021.
  • The 5-year median for Goodwill is $4.5 million (2021), against an average of $4.5 million.
  • The largest YoY upside for Goodwill was 0.0% in 2022 against a maximum downside of 0.0% in 2022.
  • A 5-year view of Goodwill shows it stood at $4.5 million in 2021, then changed by 0.0% to $4.5 million in 2022, then changed by 0.0% to $4.5 million in 2023, then changed by 0.0% to $4.5 million in 2024, then changed by 0.0% to $4.5 million in 2025.
  • Per Business Quant, the three most recent readings for TXG's Goodwill are $4.5 million (Q4 2025), $4.5 million (Q3 2025), and $4.5 million (Q2 2025).